Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH17 DNAH9 DNAH11	5.40e-05	18	83	3	GO:0008569
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH17 DNAH9 DNAH11	2.10e-04	28	83	3	GO:0051959
Domain	Acetyltransf_13	ESCO2 ESCO1	1.86e-05	2	81	2	PF13880
Domain	zf-C2H2_3	ESCO2 ESCO1	1.86e-05	2	81	2	PF13878
Domain	ESCO_Acetyltransf_dom	ESCO2 ESCO1	1.86e-05	2	81	2	IPR028009
Domain	AcTrfase_ESCO_Znf_dom	ESCO2 ESCO1	1.86e-05	2	81	2	IPR028005
Domain	-	DST MACF1	2.76e-04	6	81	2	3.90.1290.10
Domain	GAR	DST MACF1	2.76e-04	6	81	2	PS51460
Domain	-	DST MACF1	2.76e-04	6	81	2	3.30.920.20
Domain	GAS_dom	DST MACF1	2.76e-04	6	81	2	IPR003108
Domain	GAS2	DST MACF1	2.76e-04	6	81	2	PF02187
Domain	GAS2	DST MACF1	2.76e-04	6	81	2	SM00243
Domain	UmuC	ESCO2 ESCO1	2.76e-04	6	81	2	IPR001126
Domain	Plectin_repeat	DST MACF1	3.85e-04	7	81	2	IPR001101
Domain	Plectin	DST MACF1	3.85e-04	7	81	2	PF00681
Domain	PLEC	DST MACF1	3.85e-04	7	81	2	SM00250
Domain	DHC_N1	DNAH9 DNAH11	5.11e-04	8	81	2	PF08385
Domain	Dynein_heavy_dom-1	DNAH9 DNAH11	5.11e-04	8	81	2	IPR013594
Domain	DOCK_C	DOCK4 DOCK9	9.96e-04	11	81	2	IPR010703
Domain	DHR-1_domain	DOCK4 DOCK9	9.96e-04	11	81	2	IPR027007
Domain	DHR_2	DOCK4 DOCK9	9.96e-04	11	81	2	PS51651
Domain	DHR_1	DOCK4 DOCK9	9.96e-04	11	81	2	PS51650
Domain	DOCK-C2	DOCK4 DOCK9	9.96e-04	11	81	2	PF14429
Domain	DHR-2	DOCK4 DOCK9	9.96e-04	11	81	2	IPR027357
Domain	DHR-2	DOCK4 DOCK9	9.96e-04	11	81	2	PF06920
Domain	DOCK	DOCK4 DOCK9	9.96e-04	11	81	2	IPR026791
Domain	Quinoprotein_ADH-like_supfam	WDR75 WDR88 FBXW2	1.57e-03	53	81	3	IPR011047
Domain	Dynein_heavy_chain_D4_dom	DNAH9 DNAH11	1.63e-03	14	81	2	IPR024317
Domain	Dynein_HC_stalk	DNAH9 DNAH11	1.63e-03	14	81	2	IPR024743
Domain	Dynein_heavy_dom-2	DNAH9 DNAH11	1.63e-03	14	81	2	IPR013602
Domain	DHC_N2	DNAH9 DNAH11	1.63e-03	14	81	2	PF08393
Domain	MT	DNAH9 DNAH11	1.63e-03	14	81	2	PF12777
Domain	AAA_8	DNAH9 DNAH11	1.63e-03	14	81	2	PF12780
Domain	TIL_dom	LRP2 MUC2	1.63e-03	14	81	2	IPR002919
Domain	ATPase_dyneun-rel_AAA	DNAH9 DNAH11	1.63e-03	14	81	2	IPR011704
Domain	AAA_5	DNAH9 DNAH11	1.63e-03	14	81	2	PF07728
Domain	DHC_fam	DNAH9 DNAH11	1.88e-03	15	81	2	IPR026983
Domain	Dynein_heavy_dom	DNAH9 DNAH11	1.88e-03	15	81	2	IPR004273
Domain	Dynein_heavy	DNAH9 DNAH11	1.88e-03	15	81	2	PF03028
Domain	Kinase-like_dom	TGFBR2 AKT3 DST PIK3CA MAP3K10 MACF1 MELK ARAF	2.40e-03	542	81	8	IPR011009
Pathway	KEGG_MEDICUS_REFERENCE_NRG_ERBB4_PI3K_SIGNALING_PATHWAY	AKT3 PIK3CA NRG3	1.37e-05	11	63	3	M47756
Pathway	REACTOME_SIGNALING_BY_ERBB2	USP8 AKT3 PIK3CA NRG3	4.30e-05	44	63	4	MM14520
Pathway	REACTOME_SIGNALING_BY_ERBB2	USP8 AKT3 PIK3CA NRG3	7.15e-05	50	63	4	M553
Pathway	KEGG_COLORECTAL_CANCER	TGFBR2 AKT3 PIK3CA ARAF	1.66e-04	62	63	4	M14631
Pathway	KEGG_MEDICUS_REFERENCE_COHESIN_ACETYLATION	ESCO2 ESCO1	1.95e-04	5	63	2	M49003
Pathway	REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING	USP8 AKT3 NRG3	2.06e-04	26	63	3	MM15501
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT	DNAH17 DNAH9 DNAH11	2.30e-04	27	63	3	M47755
Pathway	KEGG_PANCREATIC_CANCER	TGFBR2 AKT3 PIK3CA ARAF	2.66e-04	70	63	4	M9726
Pathway	REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING	USP8 AKT3 NRG3	2.86e-04	29	63	3	M27756
Pathway	KEGG_CHRONIC_MYELOID_LEUKEMIA	TGFBR2 AKT3 PIK3CA ARAF	3.13e-04	73	63	4	M321
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PI3K_TO_PI3K_SIGNALING_PATHWAY	AKT3 PIK3CA	4.07e-04	7	63	2	M47407
Pathway	KEGG_MEDICUS_REFERENCE_ACH_CHRN_PI3K_SIGNALING_PATHWAY	AKT3 PIK3CA	4.07e-04	7	63	2	M47790
Pathway	WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION	AKT3 PIK3CA ITPR1	4.22e-04	33	63	3	M39745
Pathway	KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PI3K_SIGNALING_PATHWAY	AKT3 PIK3CA	5.41e-04	8	63	2	M47399
Pathway	KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PI3K_SIGNALING_PATHWAY	AKT3 PIK3CA	5.41e-04	8	63	2	M47394
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PI3K_SIGNALING_PATHWAY	AKT3 PIK3CA	5.41e-04	8	63	2	M47395
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_PI3K_SIGNALING_PATHWAY	AKT3 PIK3CA	5.41e-04	8	63	2	M47404
Pathway	KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY	AKT3 PIK3CA	5.41e-04	8	63	2	M47405
Pathway	KEGG_MEDICUS_REFERENCE_P4_PR_PI3K_SIGNALING_PATHWAY	AKT3 PIK3CA	5.41e-04	8	63	2	M47803
Pathway	KEGG_MEDICUS_VARIANT_TGFA_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY	AKT3 PIK3CA	5.41e-04	8	63	2	M47482
Pathway	KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY	AKT3 PIK3CA	5.41e-04	8	63	2	M47498
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_RET_TO_PI3K_SIGNALING_PATHWAY	AKT3 PIK3CA	5.41e-04	8	63	2	M47715
Pathway	REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING	PIK3CA NRG3	5.41e-04	8	63	2	MM14532
Pathway	SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES	AKT3 PIK3CA ITPR1	5.47e-04	36	63	3	M1315
Pathway	KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	AKT3 PIK3CA ANAPC5 ARAF	5.59e-04	85	63	4	M3578
Pathway	KEGG_ERBB_SIGNALING_PATHWAY	AKT3 PIK3CA NRG3 ARAF	6.11e-04	87	63	4	M12467
Pathway	WP_PANCREATIC_ADENOCARCINOMA_PATHWAY	TGFBR2 AKT3 PIK3CA ARAF	6.66e-04	89	63	4	M39732
Pathway	KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_PI3K_SIGNALING_PATHWAY	AKT3 PIK3CA	6.93e-04	9	63	2	M47397
Pathway	KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_SIGNALING_PATHWAY	AKT3 PIK3CA	6.93e-04	9	63	2	M47392
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_PI3K_SIGNALING_PATHWAY	AKT3 PIK3CA	6.93e-04	9	63	2	M47391
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_PI3K_SIGNALING_PATHWAY	AKT3 PIK3CA	6.93e-04	9	63	2	M47402
Pathway	KEGG_MEDICUS_REFERENCE_MEMBRANE_INITIATED_PROGESTERONE_SIGNALING_PATHWAY	AKT3 PIK3CA	6.93e-04	9	63	2	M47802
Pathway	KEGG_MEDICUS_VARIANT_AMPLIFIED_MET_TO_PI3K_SIGNALING_PATHWAY	AKT3 PIK3CA	6.93e-04	9	63	2	M47490
Pathway	KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PI3K_SIGNALING_PATHWAY	AKT3 PIK3CA	6.93e-04	9	63	2	M47481
Pathway	WP_ERBB_SIGNALING	AKT3 PIK3CA NRG3 ARAF	7.54e-04	92	63	4	M39715
Pathway	KEGG_MEDICUS_VARIANT_EGFR_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY	AKT3 PIK3CA	8.64e-04	10	63	2	M47400
Pathway	KEGG_MEDICUS_REFERENCE_HGF_MET_PI3K_SIGNALING_PATHWAY	AKT3 PIK3CA	8.64e-04	10	63	2	M47401
Pathway	KEGG_MEDICUS_REFERENCE_CD80_CD86_CD28_PI3K_SIGNALING_PATHWAY	AKT3 PIK3CA	8.64e-04	10	63	2	M47615
Pathway	REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING	PIK3CA NRG3	8.64e-04	10	63	2	M568
Pathway	KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT	DNAH17 DNAH9 DNAH11	9.24e-04	43	63	3	M47669
Pathway	KEGG_MEDICUS_ENV_FACTOR_NICOTINE_NNK_TO_PI3K_SIGNALING_PATHWAY	AKT3 PIK3CA	1.05e-03	11	63	2	M47797
Pathway	KEGG_MEDICUS_REFERENCE_KITLG_KIT_PI3K_SIGNALING_PATHWAY	AKT3 PIK3CA	1.05e-03	11	63	2	M47403
Pathway	KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY	AKT3 PIK3CA	1.05e-03	11	63	2	M47406
Pathway	REACTOME_ESTABLISHMENT_OF_SISTER_CHROMATID_COHESION	ESCO2 ESCO1	1.05e-03	11	63	2	M27177
Pathway	REACTOME_ESTABLISHMENT_OF_SISTER_CHROMATID_COHESION	ESCO2 ESCO1	1.05e-03	11	63	2	MM14891
Pathway	KEGG_MEDICUS_REFERENCE_IGF2_IGF1R_PI3K_SIGNALING_PATHWAY	AKT3 PIK3CA	1.05e-03	11	63	2	M47484
Pathway	KEGG_MEDICUS_REFERENCE_EREG_EGFR_PI3K_SIGNALING_PATHWAY	AKT3 PIK3CA	1.05e-03	11	63	2	M47499
Pathway	KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01339	AKT3 PIK3CA	1.05e-03	11	63	2	M47791
Pathway	KEGG_MEDICUS_REFERENCE_AREG_EGFR_PI3K_SIGNALING_PATHWAY	AKT3 PIK3CA	1.05e-03	11	63	2	M47501
Pathway	SIG_CHEMOTAXIS	AKT3 PIK3CA ITPR1	1.06e-03	45	63	3	M5193
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT	DNAH17 DNAH9 DNAH11	1.06e-03	45	63	3	M47670
Pathway	WP_ERBB_SIGNALING_PATHWAY	AKT3 NRG3 ARAF	1.13e-03	46	63	3	MM15950
Pathway	SIG_BCR_SIGNALING_PATHWAY	AKT3 PIK3CA ITPR1	1.13e-03	46	63	3	M8626
Pathway	KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY	AKT3 PIK3CA	1.26e-03	12	63	2	M47393
Pathway	KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01350	AKT3 PIK3CA	1.26e-03	12	63	2	M47798
Pathway	KEGG_MEDICUS_REFERENCE_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY	AKT3 PIK3CA	1.26e-03	12	63	2	M47558
Pathway	KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY	AKT3 PIK3CA	1.26e-03	12	63	2	M47559
Pathway	REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING	USP8 AKT3	1.26e-03	12	63	2	MM14550
Pathway	KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PI3K_SIGNALING_PATHWAY	AKT3 PIK3CA	1.49e-03	13	63	2	M47398
Pathway	KEGG_MEDICUS_REFERENCE_IGF_IGF1R_PI3K_SIGNALING_PATHWAY	AKT3 PIK3CA	1.49e-03	13	63	2	M47603
Pathway	REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING	USP8 AKT3	1.49e-03	13	63	2	M549
Pathway	KEGG_ENDOMETRIAL_CANCER	AKT3 PIK3CA ARAF	1.61e-03	52	63	3	M19877
Pathway	KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY	AKT3 PIK3CA	1.73e-03	14	63	2	M47390
Pathway	KEGG_MEDICUS_REFERENCE_IGF_IGFR_PI3K_NFKB_SIGNALING_PATHWAY	AKT3 PIK3CA	1.73e-03	14	63	2	M47467
Pathway	KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_NFKB_SIGNALING_PATHWAY	AKT3 PIK3CA	1.73e-03	14	63	2	M47536
Pathway	REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING	PIK3CA NRG3	1.73e-03	14	63	2	MM14761
Pathway	KEGG_NON_SMALL_CELL_LUNG_CANCER	AKT3 PIK3CA ARAF	1.79e-03	54	63	3	M19818
Pathway	WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS	AKT3 PIK3CA MAP3K10 ITPR1	1.96e-03	119	63	4	M48309
Pathway	KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY	AKT3 PIK3CA	1.99e-03	15	63	2	M47389
Pathway	KEGG_MEDICUS_REFERENCE_RELN_VLDLR_PI3K_SIGNALING_PATHWAY	AKT3 PIK3CA	1.99e-03	15	63	2	M47663
Pathway	KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY	AKT3 PIK3CA	1.99e-03	15	63	2	M47475
Pathway	WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS	AKT3 PIK3CA	1.99e-03	15	63	2	M48306
Pathway	KEGG_ACUTE_MYELOID_LEUKEMIA	AKT3 PIK3CA ARAF	2.10e-03	57	63	3	M19888
Pathway	REACTOME_SIGNALING_BY_GPCR	GHSR AKT3 DRD2 PIK3CA NPSR1 C5 TAS2R31 BDKRB2 ITPR1	2.18e-03	646	63	9	MM14962
Pathway	REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING	PIK3CA NRG3	2.27e-03	16	63	2	M570
Pathway	WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA	AKT3 PIK3CA ARAF	2.31e-03	59	63	3	M39750
Pathway	REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS	GHSR PIK3CA NPSR1 BDKRB2 ITPR1	2.44e-03	210	63	5	MM15043
Pathway	SA_PTEN_PATHWAY	AKT3 PIK3CA	2.56e-03	17	63	2	M12771
Pathway	SA_TRKA_RECEPTOR	AKT3 PIK3CA	2.56e-03	17	63	2	M18895
Pathway	WP_ENDOMETRIAL_CANCER	AKT3 PIK3CA ARAF	2.79e-03	63	63	3	M39623
Pathway	REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS	GHSR PIK3CA NPSR1 BDKRB2 ITPR1	2.81e-03	217	63	5	M18437
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	ESCO2 ZWILCH AKT3 WDR75 ALDH1L2 DOCK9 UGGT1 DTL LRP2 MACF1 RTN4IP1 XPA SBNO2 LRRC71 ITPR1	3.88e-08	1084	83	15	11544199
Pubmed	Mutations in DNAH17, Encoding a Sperm-Specific Axonemal Outer Dynein Arm Heavy Chain, Cause Isolated Male Infertility Due to Asthenozoospermia.	DNAH17 DNAH9 DNAH11	4.56e-07	7	83	3	31178125
Pubmed	Temporal Regulation of ESCO2 Degradation by the MCM Complex, the CUL4-DDB1-VPRBP Complex, and the Anaphase-Promoting Complex.	ESCO2 MCM10 ESCO1	2.13e-06	11	83	3	30100344
Pubmed	A protein interaction landscape of breast cancer.	DOCK4 AKT3 DST PIK3CA UGGT1 MACF1 MYO1B MCM10 NOP2 ARAF	2.78e-06	634	83	10	34591612
Pubmed	Knockdown of AKT3 (PKBγ) and PI3KCA suppresses cell viability and proliferation and induces the apoptosis of glioblastoma multiforme T98G cells.	AKT3 PIK3CA	5.63e-06	2	83	2	24967401
Pubmed	Combination Therapy with AKT3 and PI3KCA siRNA Enhances the Antitumor Effect of Temozolomide and Carmustine in T98G Glioblastoma Multiforme Cells.	AKT3 PIK3CA	5.63e-06	2	83	2	26902608
Pubmed	Acf7 (MACF) is an actin and microtubule linker protein whose expression predominates in neural, muscle, and lung development.	DST MACF1	5.63e-06	2	83	2	11002341
Pubmed	GHSR-D2R heteromerization modulates dopamine signaling through an effect on G protein conformation.	GHSR DRD2	5.63e-06	2	83	2	29632174
Pubmed	PI3K/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia.	AKT3 PIK3CA	5.63e-06	2	83	2	25722288
Pubmed	Genomic, Transcriptomic, Epigenetic, and Immune Profiling of Mucinous Breast Cancer.	PIK3CA MUC2	5.63e-06	2	83	2	30789657
Pubmed	Two human orthologues of Eco1/Ctf7 acetyltransferases are both required for proper sister-chromatid cohesion.	ESCO2 ESCO1	5.63e-06	2	83	2	15958495
Pubmed	Endocytosis provides a major alternative pathway for lysosomal biogenesis in kidney proximal tubular cells.	CLCN5 LRP2	5.63e-06	2	83	2	17369355
Pubmed	DOCK4 stimulates MUC2 production through its effect on goblet cell differentiation.	DOCK4 MUC2	5.63e-06	2	83	2	33559155
Pubmed	Esco1 and Esco2 regulate distinct cohesin functions during cell cycle progression.	ESCO2 ESCO1	5.63e-06	2	83	2	28847955
Pubmed	Dopamine and ghrelin receptor co-expression and interaction in the spinal defecation centers.	GHSR DRD2	5.63e-06	2	83	2	33264473
Pubmed	Bradykinin B2 and dopamine D2 receptors form a functional dimer.	DRD2 BDKRB2	5.63e-06	2	83	2	28757212
Pubmed	Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.	DST DIS3L UGGT1 AOAH TMEM266 UGT8 RRM1 TTF1 MELK PLEKHO1 SBNO2 DOP1B ZNF3	1.15e-05	1293	83	13	15342556
Pubmed	Analysis of interaction partners for eukaryotic translation elongation factor 1A M-domain by functional proteomics.	DST DNAH17 MACF1	1.45e-05	20	83	3	21689717
Pubmed	Sodium butyrate induces differentiation of gastric cancer cells to intestinal cells via the PTEN/phosphoinositide 3-kinase pathway.	PIK3CA MUC2	1.69e-05	3	83	2	20718712
Pubmed	Expression of the mouse Macf2 gene during inner ear development.	DST MACF1	1.69e-05	3	83	2	12399109
Pubmed	Non-redundant roles in sister chromatid cohesion of the DNA helicase DDX11 and the SMC3 acetyl transferases ESCO1 and ESCO2.	ESCO2 ESCO1	1.69e-05	3	83	2	31935221
Pubmed	Mutational analysis of PHEX, FGF23 and CLCN5 in patients with hypophosphataemic rickets.	PHEX CLCN5	1.69e-05	3	83	2	28383812
Pubmed	Therapeutic priority of the PI3K/AKT/mTOR pathway in small cell lung cancers as revealed by a comprehensive genomic analysis.	AKT3 PIK3CA	1.69e-05	3	83	2	25122428
Pubmed	Possible involvement of type 1 inositol 1,4,5-trisphosphate receptors up-regulated by dopamine D1 and D2 receptors in mouse nucleus accumbens neurons in the development of methamphetamine-induced place preference.	DRD2 ITPR1	1.69e-05	3	83	2	23000618
Pubmed	Short-term functional adaptation of aquaporin-1 surface expression in the proximal tubule, a component of glomerulotubular balance.	CLCN5 LRP2	1.69e-05	3	83	2	25270072
Pubmed	Knockdown of the AKT3 (PKBγ), PI3KCA, and VEGFR2 genes by RNA interference suppresses glioblastoma multiforme T98G cells invasiveness in vitro.	AKT3 PIK3CA	1.69e-05	3	83	2	25501707
Pubmed	Alternative catalytic residues in the active site of Esco acetyltransferases.	ESCO2 ESCO1	1.69e-05	3	83	2	32555289
Pubmed	Mutational analysis of PHEX, FGF23, DMP1, SLC34A3 and CLCN5 in patients with hypophosphatemic rickets.	PHEX CLCN5	1.69e-05	3	83	2	22695891
Pubmed	Loss of chloride channel ClC-5 impairs endocytosis by defective trafficking of megalin and cubilin in kidney proximal tubules.	CLCN5 LRP2	1.69e-05	3	83	2	12815097
Pubmed	Regulation of type 1 IP₃ receptor expression by dopamine D2-like receptors via AP-1 and NFATc4 activation.	DRD2 ITPR1	1.69e-05	3	83	2	23597509
Pubmed	De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly.	AKT3 PIK3CA	1.69e-05	3	83	2	22729223
Pubmed	De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes.	AKT3 PIK3CA	1.69e-05	3	83	2	22729224
Pubmed	Regulation of type 1 inositol 1,4,5-triphosphate receptor by dopamine receptors in cocaine-induced place conditioning.	DRD2 ITPR1	1.69e-05	3	83	2	22033896
Pubmed	Human parietal epithelial cells (PECs) and proteinuria in lupus nephritis: a role for ClC-5, megalin, and cubilin?	CLCN5 LRP2	1.69e-05	3	83	2	37594671
Pubmed	Local anesthetics impair the growth and self-renewal of glioblastoma stem cells by inhibiting ZDHHC15-mediated GP130 palmitoylation.	DOCK4 MCTP1 LRP2 IL6ST	2.59e-05	71	83	4	33541421
Pubmed	A novel renal carbonic anhydrase type III plays a role in proximal tubule dysfunction.	CLCN5 LRP2	3.37e-05	4	83	2	18322545
Pubmed	Expressed Gene Fusions as Frequent Drivers of Poor Outcomes in Hormone Receptor-Positive Breast Cancer.	AKT3 PIK3CA	3.37e-05	4	83	2	29242214
Pubmed	Clustering of Genetic Anomalies of Cilia Outer Dynein Arm and Central Apparatus in Patients with Transposition of the Great Arteries.	DNAH9 DNAH11	3.37e-05	4	83	2	36140829
Pubmed	Apolipoprotein M modulates erythrocyte efflux and tubular reabsorption of sphingosine-1-phosphate.	CLCN5 LRP2	3.37e-05	4	83	2	24950692
Pubmed	Identification and characterization of a novel Nogo-interacting mitochondrial protein (NIMP).	RTN4 RTN4IP1	3.37e-05	4	83	2	12067236
Pubmed	Cloning and characterization of mouse ACF7, a novel member of the dystonin subfamily of actin binding proteins.	DST MACF1	3.37e-05	4	83	2	8954775
Pubmed	Ubiquitin-specific peptidase 8 (USP8) regulates endosomal trafficking of the epithelial Na+ channel.	USP8 SCNN1B	3.37e-05	4	83	2	23297398
Pubmed	Casein kinase 2-interacting protein-1, a novel Akt pleckstrin homology domain-interacting protein, down-regulates PI3K/Akt signaling and suppresses tumor growth in vivo.	AKT3 PLEKHO1	3.37e-05	4	83	2	17942896
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	DOCK4 USP8 DST DTL MAP3K10 MACF1 MLXIP MELK ARAF DOP1B	3.91e-05	861	83	10	36931259
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	KLHL29 TRANK1 PIEZO1 RNF213 MLXIP MUC2 ITPR1 DNAH11	5.32e-05	552	83	8	10737800
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	KLHL29 DOCK4 USP8 DOCK9 MACF1 MLXIP DOP1B	5.52e-05	407	83	7	12693553
Pubmed	USP8 promotes cancer progression and extracellular vesicle-mediated CD8+ T cell exhaustion by deubiquitinating the TGF-β receptor TβRII.	TGFBR2 USP8	5.60e-05	5	83	2	35811497
Pubmed	Expression of matrix metalloproteinase-13 is controlled by IL-13 via PI3K/Akt3 and PKC-δ in normal human dermal fibroblasts.	AKT3 PIK3CA	5.60e-05	5	83	2	21191416
Pubmed	DNAH11 Localization in the Proximal Region of Respiratory Cilia Defines Distinct Outer Dynein Arm Complexes.	DNAH9 DNAH11	5.60e-05	5	83	2	26909801
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	USP8 DST NUDT5 DOCK9 RTN4 MACF1 MYO1B IL6ST	6.26e-05	565	83	8	25468996
Pubmed	Cohesin acetylation speeds the replication fork.	ESCO2 ESCO1	8.39e-05	6	83	2	19907496
Pubmed	Epithelial sodium channel regulated by differential composition of a signaling complex.	PIK3CA SCNN1B	8.39e-05	6	83	2	19380724
Pubmed	TLR4 ligand/H₂O₂ enhances TGF-β1 signaling to induce metastatic potential of non-invasive breast cancer cells by activating non-Smad pathways.	TGFBR2 PIK3CA	8.39e-05	6	83	2	23734265
Pubmed	CFAP53 regulates mammalian cilia-type motility patterns through differential localization and recruitment of axonemal dynein components.	DNAH9 DNAH11	8.39e-05	6	83	2	33347437
Pubmed	The prognostic impact of Akt isoforms, PI3K and PTEN related to female steroid hormone receptors in soft tissue sarcomas.	AKT3 PIK3CA	8.39e-05	6	83	2	22107784
Pubmed	Mutational and immunohistochemical study of the PI3K/Akt pathway in papillary thyroid carcinoma in Greece.	AKT3 PIK3CA	8.39e-05	6	83	2	20186503
Pubmed	Lysine acetylation targets protein complexes and co-regulates major cellular functions.	USP8 RNF213 ARAF	1.04e-04	38	83	3	19608861
Pubmed	New member of the Snf1/AMPK kinase family, Melk, is expressed in the mouse egg and preimplantation embryo.	XPA MELK	1.17e-04	7	83	2	9136115
Pubmed	CFAP45 deficiency causes situs abnormalities and asthenospermia by disrupting an axonemal adenine nucleotide homeostasis module.	DNAH17 DNAH11	1.17e-04	7	83	2	33139725
Pubmed	Epidemiology of the antibiotic resistance of Helicobacter pylori in Canada.	ESCO2 ESCO1	1.17e-04	7	83	2	11111111
Pubmed	Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers.	ANO2 ALDH1L2 NPSR1 NRG3 IL6ST	1.18e-04	199	83	5	23382691
Pubmed	Phosphoproteome analysis of the human mitotic spindle.	WDR75 PIEZO1 PRC1 TTF1 NOP2	1.52e-04	210	83	5	16565220
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	RBM25 DST WDR75 UGGT1 MACF1 MYO1B TTF1 NOP2	1.69e-04	653	83	8	22586326
Pubmed	Interaction proteomics analysis of polycomb proteins defines distinct PRC1 complexes in mammalian cells.	ESCO2 TRANK1 RNF213 NOP2	1.76e-04	116	83	4	21282530
Pubmed	Phosphorylation-dependent interaction of kinesin light chain 2 and the 14-3-3 protein.	PIK3CA ARAF	2.00e-04	9	83	2	11969417
Pubmed	Novel PI3K/Akt inhibitors screened by the cytoprotective function of human immunodeficiency virus type 1 Tat.	AKT3 PIK3CA	2.00e-04	9	83	2	21765914
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	DST WDR75 ALDH1L2 RTN4 DTL LRP2 RNF213 RTN4IP1 DBT NOP2 ARAF ITPR1	2.20e-04	1496	83	12	32877691
Pubmed	An improved smaller biotin ligase for BioID proximity labeling.	DST LMLN TTF1 DNAH9	2.21e-04	123	83	4	26912792
Pubmed	Sororin mediates sister chromatid cohesion by antagonizing Wapl.	ESCO2 ESCO1	2.50e-04	10	83	2	21111234
Pubmed	Cohesion establishment factor, Eco1 represses transcription via association with histone demethylase, LSD1.	ESCO2 ESCO1	2.50e-04	10	83	2	20331966
Pubmed	Angiogenesis selectively requires the p110alpha isoform of PI3K to control endothelial cell migration.	AKT3 PIK3CA	3.05e-04	11	83	2	18449193
Pubmed	Platelet-derived growth factor CC-mediated neuroprotection against HIV Tat involves TRPC-mediated inactivation of GSK 3beta.	AKT3 PIK3CA	3.05e-04	11	83	2	23077641
Pubmed	The role of microtubule actin cross-linking factor 1 (MACF1) in the Wnt signaling pathway.	DST MACF1	3.05e-04	11	83	2	16815997
Pubmed	HIV-1 Nef and KSHV oncogene K1 synergistically promote angiogenesis by inducing cellular miR-718 to regulate the PTEN/AKT/mTOR signaling pathway.	AKT3 PIK3CA	3.05e-04	11	83	2	25104021
Pubmed	Appl1 is dispensable for Akt signaling in vivo and mouse T-cell development.	AKT3 PIK3CA	3.66e-04	12	83	2	20665729
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	FAT4 DST LRP2 RNF213 TAS2R31 NIPAL3 ESCO1 DOP1B	3.78e-04	736	83	8	29676528
Pubmed	Identification of different proteins binding to Na, K-ATPase α1 in LPS-induced ARDS cell model by proteomic analysis.	RTN4 RNF213 MYO1B NOP2	4.02e-04	144	83	4	35681168
Pubmed	The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA.	WDR75 UGGT1 RNF213 NOP2 SBNO2	4.20e-04	262	83	5	36880596
Pubmed	Extracellular HIV-1 Tat protein activates phosphatidylinositol 3- and Akt/PKB kinases in CD4+ T lymphoblastoid Jurkat cells.	AKT3 PIK3CA	4.31e-04	13	83	2	9394803
Pubmed	Heart and liver defects and reduced transforming growth factor beta2 sensitivity in transforming growth factor beta type III receptor-deficient embryos.	TGFBR2 AKT3	5.03e-04	14	83	2	12773577
Pubmed	Infection of human immunodeficiency virus and intracellular viral Tat protein exert a pro-survival effect in a human microglial cell line.	AKT3 PIK3CA	5.03e-04	14	83	2	17157319
Pubmed	Identification of dynein heavy chain genes expressed in human and mouse testis: chromosomal localization of an axonemal dynein gene.	DNAH17 DNAH11	5.03e-04	14	83	2	9373155
Pubmed	TGF-β specifies TFH versus TH17 cell fates in murine CD4+ T cells through c-Maf.	TGFBR2 IL6ST	5.03e-04	14	83	2	38427718
Pubmed	Identification of an evolutionarily conserved superfamily of DOCK180-related proteins with guanine nucleotide exchange activity.	DOCK4 DOCK9	5.03e-04	14	83	2	12432077
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	FAT4 POMGNT2 PIEZO1 RTN4 UGGT1 UGT8 RNF213 RRM1 IL6ST ITPR1	5.75e-04	1201	83	10	35696571
Pubmed	Mutation specific functions of EGFR result in a mutation-specific downstream pathway activation.	DOCK4 PIK3CA UGGT1	5.87e-04	68	83	3	25754235
Pubmed	Proteomic Analysis Reveals a Role for RSK in p120-catenin Phosphorylation and Melanoma Cell-Cell Adhesion.	DOCK4 GGA2 MACF1 ARAF	5.98e-04	160	83	4	31678930
Pubmed	A CRISPR-based screen for Hedgehog signaling provides insights into ciliary function and ciliopathies.	DST CSTL1 UGGT1 C5 ESCO1	6.05e-04	284	83	5	29459677
Pubmed	Akt/Nox2/NF-κB signaling pathway is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation.	AKT3 PIK3CA	6.61e-04	16	83	2	21029719
Pubmed	Erythropoietin plus insulin-like growth factor-I protects against neuronal damage in a murine model of human immunodeficiency virus-associated neurocognitive disorders.	AKT3 PIK3CA	6.61e-04	16	83	2	20818790
Pubmed	HIV-1 gp120-mediated apoptosis of T cells is regulated by the membrane tyrosine phosphatase CD45.	AKT3 PIK3CA	6.61e-04	16	83	2	16524887
Pubmed	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	KLHL29 ANO2 AOAH MYO1B XPA NRG3 SDK1 ITPR1	7.32e-04	814	83	8	23251661
Pubmed	Identification of RanBP 9/10 as interacting partners for protein kinase C (PKC) gamma/delta and the D1 dopamine receptor: regulation of PKC-mediated receptor phosphorylation.	MACF1 ITPR1	7.48e-04	17	83	2	20395553
Pubmed	Synergistic cooperation between methamphetamine and HIV-1 gsp120 through the P13K/Akt pathway induces IL-6 but not IL-8 expression in astrocytes.	AKT3 PIK3CA	7.48e-04	17	83	2	23251686
Pubmed	Identification of novel human WW domain-containing proteins by cloning of ligand targets.	CLCN5 SCNN1B	8.40e-04	18	83	2	9169421
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	ESCO2 DST NUDT5 MCM10 DBT PRC1 NOP2	8.97e-04	645	83	7	25281560
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	DOCK4 GGA2 NUDT5 DIS3L LRP2 MLXIP DBT ARAF	9.89e-04	853	83	8	28718761
Pubmed	ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.	RBM25 DST WDR75 UGGT1 MACF1 PRC1 NOP2	1.03e-03	660	83	7	32780723
Pubmed	Dnmt1 is essential to maintain progenitors in the perinatal intestinal epithelium.	MCM10 MUC2	1.04e-03	20	83	2	26023099
Pubmed	Cyclin F-mediated degradation of ribonucleotide reductase M2 controls genome integrity and DNA repair.	FBXW2 RRM1	1.04e-03	20	83	2	22632967
GeneFamily	Dyneins, axonemal	DNAH17 DNAH9 DNAH11	1.96e-05	17	57	3	536
GeneFamily	EF-hand domain containing\|Plakins	DST MACF1	2.70e-04	8	57	2	939
Coexpression	LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES	DOCK4 TGFBR2 AKT3 MACF1 NRG3 IL6ST	4.96e-06	137	83	6	M39241
Coexpression	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN	ZWILCH DTL MCM10 RRM1	8.66e-06	41	83	4	M19002
Coexpression	MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	DTL PRC1 RRM1 MELK ANAPC5	8.98e-06	88	83	5	M19287
Coexpression	LAKE_ADULT_KIDNEY_C24_ENDOTHELIAL_CELLS_AEA_AND_DVR	DOCK4 AKT3 DST DOCK9 MACF1 IL6ST	9.00e-06	152	83	6	M39243
Coexpression	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	DTL MCM10 PRC1 RRM1 MELK	9.50e-06	89	83	5	M5198
Coexpression	MORI_IMMATURE_B_LYMPHOCYTE_DN	DTL MCM10 PRC1 RRM1 MELK	1.06e-05	91	83	5	M18917
Coexpression	MORI_IMMATURE_B_LYMPHOCYTE_DN	DTL MCM10 PRC1 RRM1 MELK	1.18e-05	93	83	5	MM1138
Coexpression	MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	DTL PRC1 RRM1 MELK ANAPC5	1.18e-05	93	83	5	MM1137
Coexpression	LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS	DOCK4 AKT3 DST NRG3 IL6ST ITPR1	2.14e-05	177	83	6	M39245
Coexpression	GEORGES_TARGETS_OF_MIR192_AND_MIR215	ESCO2 DST TENT4A DIS3L LMLN DTL UGT8 MACF1 FBXW2 MCM10 DBT IL6ST	2.36e-05	892	83	12	M18120
Coexpression	HOSHIDA_LIVER_CANCER_SURVIVAL_DN	DOCK4 DST XPA C5 RRM1	3.03e-05	113	83	5	M5451
Coexpression	FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN	ESCO2 DTL UGT8 C5 PRC1 MELK	3.18e-05	190	83	6	M761
Coexpression	TRAVAGLINI_LUNG_ALVEOLAR_EPITHELIAL_TYPE_1_CELL	DOCK4 TGFBR2 DST PIEZO1 SCNN1B RNF213 MYO1B PLEKHO1	3.40e-05	391	83	8	M41659
Coexpression	FUJII_YBX1_TARGETS_DN	DTL MCM10 RRM1 MELK ITPR1 POLR3F	3.58e-05	194	83	6	M14340
Coexpression	GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_45MIN_UP	TGFBR2 GGA2 MCTP1 PIK3CA ESCO1 DOP1B	4.12e-05	199	83	6	M6638
Coexpression	LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP	ESCO2 ZWILCH CLCN5 DTL MCM10 PRC1 RRM1 MELK	4.13e-05	402	83	8	MM454
Coexpression	GSE30962_ACUTE_VS_CHRONIC_LCMV_SECONDARY_INF_CD8_TCELL_DN	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1	4.24e-05	200	83	6	M5052
Coexpression	GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP	ESCO2 ZWILCH DTL MCM10 RRM1 MELK	4.24e-05	200	83	6	M3580
Coexpression	GSE22313_HEALTHY_VS_SLE_MOUSE_CD4_TCELL_DN	AOAH DTL MCM10 PRC1 RRM1 MELK	4.24e-05	200	83	6	M8584
Coexpression	GSE10239_NAIVE_VS_DAY4.5_EFF_CD8_TCELL_DN	ZWILCH NUDT5 DTL PRC1 RRM1 MELK	4.24e-05	200	83	6	M3072
Coexpression	GEORGES_CELL_CYCLE_MIR192_TARGETS	TENT4A DTL MACF1 MCM10	4.53e-05	62	83	4	M11038
Coexpression	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	ESCO2 DOCK4 AKT3 DTL PRC1 RRM1 MELK	5.26e-05	305	83	7	M19875
Coexpression	VAN_DEN_BIGGELAAR_PBMC_PREVNAR_9MO_INFANT_STIMULATED_VS_UNSTIMULATED_9MO_UP	ESCO2 DTL MCM10 PRC1 MELK	5.29e-05	127	83	5	M40952
Coexpression	GSE11884_WT_VS_FURIN_KO_NAIVE_CD4_TCELL_DN	DST CSTL1 MLXIP BDKRB2 SBNO2	5.50e-05	128	83	5	M410
Coexpression	LAKE_ADULT_KIDNEY_C2_PODOCYTES	KLHL29 DOCK4 AKT3 DST MACF1 MYO1B	5.86e-05	212	83	6	M39221
Coexpression	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK	7.53e-05	323	83	7	M2156
Coexpression	SENESE_HDAC1_TARGETS_UP	ESCO2 DOCK4 TGFBR2 AKT3 CARNMT1 ANAPC5 IL6ST ITPR1	9.22e-05	451	83	8	M14973
Coexpression	MORI_PRE_BI_LYMPHOCYTE_UP	DTL PRC1 RRM1 MELK	1.29e-04	81	83	4	M1395
Coexpression	STEIN_ESR1_TARGETS	ZWILCH DTL MCM10 RRM1	1.42e-04	83	83	4	M9678
Coexpression	KOBAYASHI_EGFR_SIGNALING_24HR_DN	ZWILCH DTL MCM10 PRC1 RRM1 MELK	1.55e-04	253	83	6	M16010
Coexpression	LAKE_ADULT_KIDNEY_C29_UNKNOWN_NOVEL_PT_CFH_POS_SUBPOPULATION_S2	AKT3 DST MACF1 NRG3	1.63e-04	86	83	4	M39248
Coexpression	MORI_PRE_BI_LYMPHOCYTE_UP	DTL PRC1 RRM1 MELK	1.70e-04	87	83	4	MM1136
Coexpression	SENESE_HDAC3_TARGETS_UP	DOCK4 TGFBR2 AKT3 GGA2 DST CLCN5 MYO1B IL6ST	1.75e-04	495	83	8	M8451
Coexpression	GCNP_SHH_UP_LATE.V1_UP	CLCN5 PIK3CA MCM10 PRC1 RRM1	2.79e-04	181	83	5	M2641
Coexpression	BURTON_ADIPOGENESIS_3	DTL MCM10 PRC1 RRM1	3.02e-04	101	83	4	M1577
Coexpression	GSE14415_TCONV_VS_FOXP3_KO_INDUCED_TREG_DN	DTL PRC1 RRM1 NOP2 ANAPC5	3.09e-04	185	83	5	M2965
Coexpression	GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_UP	ESCO2 PRC1 RRM1 PLEKHO1 ANAPC5	3.24e-04	187	83	5	M2984
Coexpression	BURTON_ADIPOGENESIS_3	DTL MCM10 PRC1 RRM1	3.38e-04	104	83	4	MM1180
Coexpression	ZHAN_MULTIPLE_MYELOMA_MF_DN	TRANK1 DOCK9 NRG3	3.45e-04	43	83	3	M513
Coexpression	BASAKI_YBX1_TARGETS_UP	ZWILCH NUDT5 DTL MCM10 PRC1 MELK	3.46e-04	294	83	6	M14985
Coexpression	CUI_TCF21_TARGETS_2_DN	DOCK4 TGFBR2 DST PIK3CA MACF1 MYO1B DBT ESCO1 ARAF IL6ST	3.63e-04	854	83	10	M1533
Coexpression	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN	GGA2 DTL RTN4IP1 MCM10	3.63e-04	106	83	4	M9160
Coexpression	BURTON_ADIPOGENESIS_PEAK_AT_24HR	PRC1 RRM1 MELK	3.69e-04	44	83	3	M1591
Coexpression	WEST_ADRENOCORTICAL_TUMOR_UP	ZWILCH RTN4 DTL PRC1 MELK MVD	3.72e-04	298	83	6	M1918
Coexpression	GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_12H_DN	ESCO2 FAT4 DTL PLEKHO1 MVD	3.75e-04	193	83	5	M6169
Coexpression	GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN	GGA2 DIS3L MCM10 RRM1 TTF1	4.12e-04	197	83	5	M7546
Coexpression	GSE21927_SPLEEN_VS_4T1_TUMOR_MONOCYTE_BALBC_DN	TMEM266 CARNMT1 NOP2 ARAF SBNO2	4.12e-04	197	83	5	M7560
Coexpression	GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_DN	CLCN5 AOAH MAP3K10 MYO1B DNAH9	4.21e-04	198	83	5	M8400
Coexpression	GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_UP	TRANK1 UGT8 MACF1 MUC2 IL6ST	4.21e-04	198	83	5	M5591
Coexpression	ZHAN_MULTIPLE_MYELOMA_PR_UP	ZWILCH MCM10 PRC1	4.21e-04	46	83	3	M4888
Coexpression	GSE41867_NAIVE_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN	AKT3 MCTP1 PIK3CA FBXW2 XPA	4.31e-04	199	83	5	M9498
Coexpression	GSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_UP	PIEZO1 DTL ANAPC5 IL6ST ZNF3	4.31e-04	199	83	5	M5270
Coexpression	GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DN	SCNN1B C5 SDK1 ESCO1 IL6ST	4.31e-04	199	83	5	M7998
Coexpression	GSE7548_NAIVE_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_UP	DOCK4 AKT3 PIK3CA LRP2 RRM1	4.31e-04	199	83	5	M6839
Coexpression	GSE20727_DNFB_ALLERGEN_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_DN	ESCO2 DTL CARNMT1 MCM10 MELK	4.31e-04	199	83	5	M9256
Coexpression	GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN	CLCN5 C5 IL6ST MVD ACOT12	4.31e-04	199	83	5	M6066
Coexpression	LEE_EARLY_T_LYMPHOCYTE_UP	DTL MCM10 PRC1 MELK	4.33e-04	111	83	4	M7357
Coexpression	GSE2585_AIRE_KO_VS_WT_CD80_HIGH_MTEC_DN	TGFBR2 DIS3L LMLN NIPAL3 IL6ST	4.41e-04	200	83	5	M6273
Coexpression	GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP	ESCO2 AKT3 CLCN5 RTN4IP1 MELK	4.41e-04	200	83	5	M7981
Coexpression	GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_UP	ESCO2 MCM10 PRC1 RRM1 MELK	4.41e-04	200	83	5	M3577
Coexpression	HALLMARK_COMPLEMENT	PHEX DOCK4 USP8 PIK3CA DOCK9	4.41e-04	200	83	5	M5921
Coexpression	GSE14350_TREG_VS_TEFF_DN	DRD2 POMGNT2 ALDH1L2 UGT8 RRM1	4.41e-04	200	83	5	M3418
Coexpression	GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_UP	MCTP1 TENT4A PIEZO1 DBT POLR3F	4.41e-04	200	83	5	M8491
Coexpression	GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_DN	ESCO2 DTL MCM10 MELK PLEKHO1	4.41e-04	200	83	5	M9277
Coexpression	GSE21670_UNTREATED_VS_TGFB_TREATED_CD4_TCELL_UP	DRD2 DNAH17 LRP2 SDK1 ACOT12	4.41e-04	200	83	5	M7471
Coexpression	GSE40666_WT_VS_STAT1_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN	ZWILCH RNF213 MCM10 MELK PLEKHO1	4.41e-04	200	83	5	M9215
Coexpression	GOLDRATH_EFF_VS_MEMORY_CD8_TCELL_UP	CLCN5 DTL MCM10 PRC1 RRM1	4.41e-04	200	83	5	M3041
Coexpression	GSE10239_MEMORY_VS_DAY4.5_EFF_CD8_TCELL_DN	ZWILCH NUDT5 MCM10 RRM1 ITPR1	4.41e-04	200	83	5	M3074
Coexpression	HEVNER_CORTEX_RADIAL_GLIA_PROGENITORS	ZWILCH NUDT5 DTL LRP2 MCM10 PRC1 MELK	4.45e-04	432	83	7	MM419
Coexpression	DODD_NASOPHARYNGEAL_CARCINOMA_UP	ESCO2 DOCK4 ZWILCH AKT3 WDR75 DTL RNF213 MCM10 PRC1 RRM1 NOP2 MELK ANAPC5	4.60e-04	1407	83	13	M14427
Coexpression	BURTON_ADIPOGENESIS_PEAK_AT_24HR	PRC1 RRM1 MELK	4.78e-04	48	83	3	MM1181
Coexpression	HE_LIM_SUN_FETAL_LUNG_C7_PROLIFERATING_SCHWANN_CELL	ESCO2 ZWILCH PIK3CA PIEZO1 UGGT1 DTL UGT8 PRC1 MELK ARAF POLR3F	4.82e-04	1054	83	11	M45798
Coexpression	CUI_TCF21_TARGETS_2_DN	DOCK4 TGFBR2 DST PIK3CA MACF1 MYO1B DBT ESCO1 ARAF IL6ST	4.92e-04	888	83	10	MM1018
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK PLEKHO1	4.93e-04	578	83	8	M2368
Coexpression	VANTVEER_BREAST_CANCER_POOR_PROGNOSIS	DTL PRC1 MELK	5.08e-04	49	83	3	M14693
Coexpression	SANSOM_APC_TARGETS	DIS3L PIEZO1 DTL MYO1B CARNMT1	5.39e-04	209	83	5	M1755
Coexpression	MEBARKI_HCC_PROGENITOR_FZD8CRD_UP	ESCO2 ZWILCH MCM10 PRC1 RRM1 NIPAL3 MELK PLEKHO1	5.51e-04	588	83	8	M38992
Coexpression	LEE_BMP2_TARGETS_DN	KLHL29 ZWILCH NUDT5 WDR75 DTL CARNMT1 MCM10 RRM1 NOP2 MELK	5.66e-04	904	83	10	M2325
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK PLEKHO1	6.09e-04	597	83	8	MM1309
Coexpression	LEE_BMP2_TARGETS_DN	KLHL29 ZWILCH NUDT5 WDR75 DTL CARNMT1 MCM10 RRM1 NOP2 MELK	6.59e-04	922	83	10	MM1068
Coexpression	LAKE_ADULT_KIDNEY_C23_ENDOTHELIAL_CELLS_AVR	DOCK4 TGFBR2 AKT3 IL6ST	6.98e-04	126	83	4	M39242
Coexpression	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	ZWILCH GGA2 NUDT5 DTL RTN4IP1 CARNMT1 MCM10 PRC1 RRM1 TTF1 MELK POLR3F	7.31e-04	1290	83	12	M80
Coexpression	BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP	TRANK1 ALDH1L2 DNAH17 LRP2 RNF213 BDKRB2	7.32e-04	339	83	6	M34012
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE	TGFBR2 AKT3 RBM25 WDR75 DOCK9 IL6ST SBNO2	7.70e-04	474	83	7	M40991
Coexpression	DESCARTES_FETAL_THYMUS_VASCULAR_ENDOTHELIAL_CELLS	ANO2 DOCK9 MYO1B NRG3	8.07e-04	131	83	4	M40316
CoexpressionAtlas	B cells, B.GC.Sp, CD19+ IgM+ IgD- GL7+ PNA+, Spleen, avg-3	ESCO2 ZWILCH GGA2 DTL RTN4IP1 MCM10 PRC1 RRM1 MELK	1.17e-05	380	79	9	GSM538207_500
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#5_top-relative-expression-ranked_500	ESCO2 DOCK4 RNF213 SNX16 ESCO1	2.27e-05	91	79	5	gudmap_developingGonad_e12.5_ovary_k5_500
CoexpressionAtlas	DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#4_top-relative-expression-ranked_1000	ESCO2 DOCK9 RNF213 CARNMT1 SNX16 ESCO1	3.87e-05	168	79	6	gudmap_developingGonad_P2_ovary_1000_k4
CoexpressionAtlas	dev gonad_e11.5_F_PrimGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_1000	ESCO2 ZWILCH WDR75 RTN4IP1 MCM10 PRC1 NOP2 MELK POLR3F	5.49e-05	463	79	9	gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_k3_1000
CoexpressionAtlas	B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Bone marrow, avg-2	ESCO2 ZWILCH MCTP1 DTL MCM10 PRC1 RRM1 ITPR1	9.73e-05	388	79	8	GSM538352_500
CoexpressionAtlas	alpha beta T cells, NKT.44-NK1.1-.Th, aGC CD1d tet CD3e, Thymus, avg-2	ESCO2 ZWILCH DTL C5 MCM10 PRC1 RRM1 MELK	1.16e-04	398	79	8	GSM538338_500
CoexpressionAtlas	Stem Cells, SC.MEP.BM, Lineage- Kit+ Sca1- CD34- FcgR-/low, Bone marrow, avg-2	ESCO2 ZWILCH NUDT5 DTL CARNMT1 MCM10 PRC1 RRM1	1.22e-04	401	79	8	GSM791108_500
CoexpressionAtlas	Stem Cells, SC.MDP.BM, Sca1- Flt3+ MCSFR+ cKithi, Bone marrow, avg-3	ESCO2 ZWILCH MCTP1 DTL MCM10 PRC1 RRM1 MELK	1.24e-04	402	79	8	GSM791105_500
CoexpressionAtlas	DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#3_top-relative-expression-ranked_1000	ESCO2 KLHL29 PHEX FAT4 PIK3CA DTL MCM10	1.47e-04	307	79	7	gudmap_developingKidney_e15.5_Peripheral blastema_1000_k3
CoexpressionAtlas	B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Fetal Liver, avg-2	ESCO2 ZWILCH MCTP1 DTL MCM10 PRC1 RRM1 MELK	1.65e-04	419	79	8	GSM538348_500
CoexpressionAtlas	gamma delta T cells, Tgd.vg3+24alo.e17.Th, TCRd+ Vg3+ CD24-, Fetal Thymus, avg-3	ESCO2 ZWILCH AOAH DTL MCM10 PRC1 RRM1 MELK	1.65e-04	419	79	8	GSM476664_500
CoexpressionAtlas	dev gonad_e11.5_F_PrimGermCell_Oct_top-relative-expression-ranked_1000	ESCO2 ZWILCH WDR75 UGT8 RTN4IP1 CARNMT1 MCM10 PRC1 NOP2 MELK POLR3F	1.75e-04	799	79	11	gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_1000
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#5_top-relative-expression-ranked_1000	DOCK4 DOCK9 RNF213 CARNMT1 SNX16 ESCO1	2.18e-04	230	79	6	gudmap_developingGonad_e18.5_ovary_1000_k5
CoexpressionAtlas	DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#2_top-relative-expression-ranked_500	ALDH1L2 FBXW2 NIPAL3 PLEKHO1 IL6ST	3.01e-04	157	79	5	gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_500_k2
CoexpressionAtlas	dev gonad_e11.5_M_PrimGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000	ESCO2 ZWILCH WDR75 RTN4IP1 PRC1 MELK	4.02e-04	258	79	6	gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_k2_1000
CoexpressionAtlas	gamma delta T cells, Tgd.vg1+vd6-.Th, TCRd+ Vg1.1+, Thymus, avg-3	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK	4.78e-04	373	79	7	GSM605781_500
CoexpressionAtlas	DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000	AKT3 PIK3CA UGT8 FBXW2 IL6ST ITPR1 POLR3F	4.93e-04	375	79	7	gudmap_developingKidney_e15.5_cortic collect duct_1000_k4
CoexpressionAtlas	alpha beta T cells, T.DN4.Th, Lin-/lo CD25- CD44- CD28+, Thymus, avg-3	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK	5.01e-04	376	79	7	GSM791154_500
CoexpressionAtlas	dev gonad_e13.5_F_DevVascOvary_Flk_k-means-cluster#2_top-relative-expression-ranked_1000	DOCK4 FAT4 DOCK9	5.13e-04	42	79	3	gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_k2_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000	KLHL29 PHEX SPTLC3 FAT4 AKT3 DST PIK3CA UGT8 FBXW2 IL6ST	5.52e-04	769	79	10	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000
CoexpressionAtlas	DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000	AKT3 PIK3CA SCNN1B LRP2 UGT8 FBXW2 IL6ST DOP1B ITPR1 POLR3F	5.80e-04	774	79	10	gudmap_developingKidney_e15.5_cortic collect duct_1000
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000	ESCO2 DOCK4 SNX16 ESCO1	6.38e-04	105	79	4	gudmap_developingGonad_e11.5_ovary + mesonephros_k5_1000
CoexpressionAtlas	alpha beta T cells, NKT.44+NK1.1-.Th, aGC CD1d tet CD3 CD44, Thymus, avg-3	ESCO2 ZWILCH DTL C5 PRC1 RRM1 MELK	6.41e-04	392	79	7	GSM538335_500
CoexpressionAtlas	B cells, B.Pl.AA4-.BM, CD138+ AA4.1- CD43+, Bone marrow, avg-2	ESCO2 ZWILCH MCTP1 AOAH DTL PRC1 RRM1	6.61e-04	394	79	7	GSM777030_500
CoexpressionAtlas	dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000	DOCK4 FAT4 TRANK1 DST PIEZO1 DOCK9 RNF213 ESCO1 IL6ST ITPR1	6.86e-04	791	79	10	gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000
CoexpressionAtlas	alpha beta T cells, preT.DN3-4.Th, Lin-/lo CD25int CD44- CD28+, Thymus, avg-3	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK	6.91e-04	397	79	7	GSM791143_500
CoexpressionAtlas	alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK	7.01e-04	398	79	7	GSM399397_500
CoexpressionAtlas	dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000	ESCO2 ZWILCH WDR75 UGT8 RTN4IP1 MCM10 PRC1 NOP2 MELK POLR3F	7.13e-04	795	79	10	gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000
CoexpressionAtlas	B cells, proB.FrBC.FL, CD19+ IgM- CD43+ CD24+ AA4.1+ CD45R+, Fetal Liver, avg-3	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK	7.22e-04	400	79	7	GSM538358_500
CoexpressionAtlas	Stem Cells, SC.CDP.BM, Sca1- Flt3+ MCSFR+ cKitlo, Bone marrow, avg-3	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK	7.33e-04	401	79	7	GSM791114_500
CoexpressionAtlas	B cells, proB.FrBC.BM, CD19+ IgM- CD43+ AA4.1+ CD45R+, Bone marrow, avg-2	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK	7.33e-04	401	79	7	GSM399450_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_100	SPTLC3 DST	7.36e-04	11	79	2	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_100_k1
CoexpressionAtlas	alpha beta T cells, T.8Eff.Sp.OT1.d6.LisOva, CD8+ CD45.1+, Spleen, avg-3	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK	7.44e-04	402	79	7	GSM605898_500
CoexpressionAtlas	B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK	8.23e-04	409	79	7	GSM399452_500
CoexpressionAtlas	dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000	ESCO2 ZWILCH WDR75 UGT8 RNF213 RTN4IP1 MCM10 NOP2 MELK POLR3F	8.23e-04	810	79	10	gudmap_dev gonad_e13.5_M_GermCell_Oct_1000
CoexpressionAtlas	Fetal Liver, SC.STSL.FL, IgM- CD24- CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Fetal Liver, avg-2	ESCO2 ZWILCH MCTP1 DTL MCM10 PRC1 RRM1	8.34e-04	410	79	7	GSM791122_500
CoexpressionAtlas	alpha beta T cells, T.8Eff.Sp.OT1.d5.VSVOva, CD8+ CD45.1+, Spleen, avg-3	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK	8.34e-04	410	79	7	GSM538387_500
CoexpressionAtlas	Stem Cells, SC.ST34F.BM, Lineage- cKit+ Sca-1+ flk2- CD34+, Bone marrow, avg-2	ESCO2 ZWILCH NUDT5 MCTP1 DTL PRC1 RRM1	8.46e-04	411	79	7	GSM791112_500
CoexpressionAtlas	alpha beta T cells, preT.DN3B.Th, Lin-/lo CD25hi CD44- CD28+, Thymus, avg-3	ZWILCH NUDT5 DTL MCM10 PRC1 RRM1 MELK	8.71e-04	413	79	7	GSM791149_500
CoexpressionAtlas	DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#5_top-relative-expression-ranked_200	KLHL29 PHEX	8.80e-04	12	79	2	gudmap_developingKidney_e15.5_Peripheral blastema_200_k5
CoexpressionAtlas	gamma delta T cells, Tgd.vg2+24ahi.e17.Th, TCRd+ Vg2+ CD24+, Fetal Thymus, avg-3	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK	8.83e-04	414	79	7	GSM476660_500
CoexpressionAtlas	dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000	ESCO2 ZWILCH WDR75 UGT8 RNF213 RTN4IP1 CARNMT1 MCM10 PRC1 MELK	9.21e-04	822	79	10	gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000
CoexpressionAtlas	alpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK	9.21e-04	417	79	7	GSM399403_500
CoexpressionAtlas	B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Fetal Liver, avg-1	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK	9.34e-04	418	79	7	GSM538350_500
CoexpressionAtlas	DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#5_top-relative-expression-ranked_1000	AKT3 PIK3CA FBXW2 ITPR1 POLR3F	9.66e-04	203	79	5	gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k5
CoexpressionAtlas	gamma delta T cells, Tgd.vg2-24ahi.Th, TCRd+ Vg2- CD24+, Thymus, avg-2	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK	9.87e-04	422	79	7	GSM476658_500
CoexpressionAtlas	B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Fetal Liver, avg-1	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK	9.87e-04	422	79	7	GSM538357_500
CoexpressionAtlas	B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R+ CD, Fetal Liver, avg-2	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK	9.87e-04	422	79	7	GSM538355_500
CoexpressionAtlas	Fetal Liver, SC.LTSL.FL, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Fetal Liver, avg-3	ESCO2 ZWILCH MCTP1 DTL MCM10 PRC1 RRM1	1.00e-03	423	79	7	GSM791126_500
CoexpressionAtlas	B cells, MLP.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Fetal Liver, avg-3	ZWILCH MCTP1 DTL MCM10 PRC1 RRM1 MELK	1.03e-03	425	79	7	GSM791131_500
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#1_top-relative-expression-ranked_1000	ESCO2 UGT8 SNX16 ESCO1 ARAF	1.12e-03	210	79	5	gudmap_developingGonad_e14.5_ ovary_1000_k1
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	FAT4 DST MCTP1 DOCK9 DTL RNF213 MACF1 PLEKHO1	3.93e-09	200	83	8	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	343B-Myeloid-Dendritic-cDC_proliferating_1\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	ESCO2 ZWILCH NUDT5 DTL MCM10 PRC1 RRM1 MELK	3.93e-09	200	83	8	5f2fbd789cc16af411a01c3199583888b260ae91
ToppCell	343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	ESCO2 DTL MCM10 PRC1 RRM1 MELK BDKRB2	3.04e-08	169	83	7	a949f547b53126a208819bade74a1ac9b2a36ea7
ToppCell	343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)\|343B / Donor, Lineage, Cell class and subclass (all cells)	ESCO2 DTL MCM10 PRC1 RRM1 MELK BDKRB2	3.04e-08	169	83	7	195d5cd60d646ac6d40a3321b2f739917e7aef14
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANO2 FAT4 TRANK1 LRP2 DNAH9 SDK1 DNAH11	5.45e-08	184	83	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANO2 FAT4 TRANK1 LRP2 DNAH9 SDK1 DNAH11	5.45e-08	184	83	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANO2 FAT4 TRANK1 LRP2 DNAH9 SDK1 DNAH11	5.45e-08	184	83	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	droplet-Lung-3m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK	6.31e-08	188	83	7	0ec2a1b0505501ba18f10a5fce68c306a6292419
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK	7.04e-08	191	83	7	50854384fdaa0efa2e3227659d544ed09ac102f2
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic-lymphocyte-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	ESCO2 DTL SCNN1B MCM10 PRC1 RRM1 MELK	7.04e-08	191	83	7	56b45259dfc38bd5ea43b0e3adf47e7e2c043a5d
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 AKT3 DST MCTP1 DOCK9 DTL MACF1	7.83e-08	194	83	7	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK	8.11e-08	195	83	7	c1435e61e4f0cf457f26ae436936048932ceb0db
ToppCell	367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK	8.39e-08	196	83	7	9591a6a3477ed6a1e2e016f7542e38603d8b16cb
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_cycling\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK	8.39e-08	196	83	7	1d2e0b328eb822db7521b5f5724d4bd17c0bad5f
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK	8.69e-08	197	83	7	4b13335a43b9d6abc8e542e72440da7feb82fbe6
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK	8.69e-08	197	83	7	21861d8b389fafbdb7c3499684c9b6deee3dbd5e
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_cycling\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK	8.69e-08	197	83	7	8b616cde333bdbc0c591035ad9e4949155866245
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK	8.69e-08	197	83	7	ffb004c37cdd26cb7cdcd80f769a2eded65416dc
ToppCell	COVID-19_Severe-T/NK_proliferative\|World / disease group, cell group and cell class	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK	8.99e-08	198	83	7	48045689d0969ff0a14eee7086b8e19b0d6b6065
ToppCell	343B-Myeloid-Dendritic-cDC_proliferating_1\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK	8.99e-08	198	83	7	281fc2536cdc4c717b30de156e563c0e4baba99d
ToppCell	Biopsy_Control_(H.)-Epithelial-Proliferating_Epithelial_cells\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK	9.31e-08	199	83	7	4fcf5bec207e4384fd73c5e8801a7e414e3ee7b0
ToppCell	367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK	9.31e-08	199	83	7	88d130e2451e61afb710edf552e6b346b9fcfb2b
ToppCell	COVID-19_Severe-T/NK_proliferative\|COVID-19_Severe / disease group, cell group and cell class	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK	9.31e-08	199	83	7	af78837f3a7641a5bd98765eef9cb4f86034048c
ToppCell	severe-Lymphocytic-Prol._cells\|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK	9.31e-08	199	83	7	b24315952b6ac6c8d2d3a7bd949a5b5392624d4e
ToppCell	distal-2-Hematologic-Proliferating_Macrophage\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK	9.63e-08	200	83	7	0cd3b01fb7f579e5abf000adb8ec8adc7cd779c4
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MCTP1 DOCK9 RNF213 MACF1 MYO1B PLEKHO1 BDKRB2	9.63e-08	200	83	7	2d07237022b409c4fac6fcf99b68c8affb3007cd
ToppCell	Biopsy_Control_(H.)-Immune-Proliferating_Macrophages\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK	9.63e-08	200	83	7	ce9fad55f779afd3d6c5a9c5a15e2d9f548b7c7e
ToppCell	NS-critical-LOC-Lymphoid-Treg\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK	9.63e-08	200	83	7	d51e5c8c154b073caaf0cc09a3a3c0aafd57e44b
ToppCell	Sepsis-ICU-NoSEP-Lymphocyte-T/NK-T/NK_proliferative\|ICU-NoSEP / Disease, condition lineage and cell class	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK	9.63e-08	200	83	7	f70cc9198339eab7fbc68f5d9b75dfb28c9afc89
ToppCell	356C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK	9.63e-08	200	83	7	2afbb5b5742b956993796621fea7e0c9888754a1
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK	9.63e-08	200	83	7	43571c9284d4e41402a2d1eefc1efe2ce8476d4a
ToppCell	356C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK	9.63e-08	200	83	7	4462ebd5d4632788f10a93fadd2babae701c754f
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK	9.63e-08	200	83	7	38665128b54f4a81b53c961427aed67bf4e2510b
ToppCell	ICU-NoSEP-Lymphocyte-T_NK-T_NK_proliferative\|ICU-NoSEP / Disease, Lineage and Cell Type	ESCO2 ZWILCH DTL MCM10 PRC1 RRM1 MELK	9.63e-08	200	83	7	d86119766b9c4f1570cd8045313345f9be46d431
ToppCell	10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8\|bone_marrow / Manually curated celltypes from each tissue	RBM25 TENT4A DOCK9 RNF213 MACF1 IL6ST	4.78e-07	156	83	6	1545169694f686d28648a68b552c2ae606599d66
ToppCell	Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	ESCO2 ZWILCH DTL MCM10 PRC1 MELK	5.75e-07	161	83	6	0dd1401b4c990d49fccb702a9f9867590a58e203
ToppCell	Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1-Mitotic.MkI67_(Mitotic.MkI67)-\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	ESCO2 ZWILCH DTL MCM10 PRC1 MELK	5.75e-07	161	83	6	b6a31c033edc74f23a20aab1f18e80cc83ffee4c
ToppCell	Globus_pallidus-Macroglia-POLYDENDROCYTE-P5\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	ESCO2 ZWILCH DTL MCM10 PRC1 MELK	5.75e-07	161	83	6	efb811dda4d73107983a5f68302bdcf4f408d5b4
ToppCell	Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1-Mitotic.MkI67_(Mitotic.MkI67)\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	ESCO2 ZWILCH DTL MCM10 PRC1 MELK	5.75e-07	161	83	6	28d5dbd20c9f8e0069f172d552997a044790e1a7
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_S-high\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ESCO2 DTL SCNN1B MCM10 RRM1 MELK	7.12e-07	167	83	6	108ae6221c6edc63c0ec42c42471b3a15a594043
ToppCell	droplet-Lung-immune-endo-depleted-3m-Lymphocytic-Proliferating_NK\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ESCO2 ZWILCH DTL PRC1 RRM1 MELK	8.18e-07	171	83	6	1eebd7138c3b20ddc1104f21615f9df0e776bbe6
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ESCO2 ZWILCH DTL PRC1 RRM1 ANAPC5	8.46e-07	172	83	6	2b6cd84c946b1e800caba452ae70145ea285fec1
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ESCO2 ZWILCH DTL PRC1 RRM1 MELK	9.05e-07	174	83	6	c988471207ba06195bc3e41056435e8c31c20bbe
ToppCell	3'_v3-Lung-Lymphocytic_T_CD4/8-lo-Cycling_T\|Lung / Manually curated celltypes from each tissue	ESCO2 DTL MCM10 PRC1 RRM1 MELK	9.67e-07	176	83	6	a40dfd8c4ba16757ff929b2f03a0628acf334de4
ToppCell	PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ESCO2 ZWILCH RTN4IP1 PRC1 NIPAL3 MELK	9.67e-07	176	83	6	8385435074cc5235b7af7424974f609388fc2cff
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ESCO2 DTL MCM10 PRC1 RRM1 MELK	1.00e-06	177	83	6	f925a15d2162d166a5b60edac3517c6b2d6cfbea
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ESCO2 DTL MCM10 PRC1 RRM1 MELK	1.10e-06	180	83	6	f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df
ToppCell	10x5'-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T\|bone_marrow / Manually curated celltypes from each tissue	ESCO2 DTL MCM10 PRC1 RRM1 MELK	1.21e-06	183	83	6	a48a6313f2f144586951cece97ec31f6d72361df
ToppCell	Striatum-Macroglia-POLYDENDROCYTE-P5\|Striatum / BrainAtlas - Mouse McCarroll V32	ESCO2 ZWILCH DTL MCM10 PRC1 MELK	1.21e-06	183	83	6	f20b0d71f857ac35868fd80531050ad8b6091716
ToppCell	IIF-Lymphocyte-T_NK-T_NK_proliferative\|IIF / Disease, Lineage and Cell Type	ESCO2 DTL MCM10 PRC1 RRM1 MELK	1.25e-06	184	83	6	ab8b45ce40e8c5f66e5c23332a591b4f9cba4ce1
ToppCell	343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ESCO2 DTL MCM10 PRC1 MELK BDKRB2	1.25e-06	184	83	6	6b2449ac65a2322aa0479fba0d89828f243aabbe
ToppCell	343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ESCO2 DTL MCM10 PRC1 MELK BDKRB2	1.25e-06	184	83	6	e90622b82fa7f16a1faaf7a4724c958f2d83341d
ToppCell	droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ESCO2 LMLN DTL MCM10 PRC1 RRM1	1.29e-06	185	83	6	47c69500877b851c0c9744f5e1ef2ee0bff99168
ToppCell	droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ESCO2 DTL MCM10 PRC1 RRM1 MELK	1.29e-06	185	83	6	57c1eb50a4456d20953e48d5dc3b0ea3d0d81b6d
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	AKT3 MCTP1 SCNN1B MYO1B SDK1 ACOT12	1.38e-06	187	83	6	e3095455d2f255854f339f6b05fa87852af0700f
ToppCell	Fibroblast-E_(Early_Fibroblastic_progenitor)\|World / shred on cell class and cell subclass (v4)	ESCO2 ANO2 DTL PRC1 RRM1 MELK	1.42e-06	188	83	6	be3db9768364568f44e32ae6b3bf99e49b0978bb
ToppCell	Multiple_Sclerosis-Lymphocyte-T_NK-T_NK_proliferative\|Multiple_Sclerosis / Disease, Lineage and Cell Type	ESCO2 DTL MCM10 PRC1 RRM1 MELK	1.42e-06	188	83	6	6c05797a5d0635d89ffcf4aca52178687129ccb4
ToppCell	367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	ESCO2 DTL MCM10 PRC1 RRM1 MELK	1.42e-06	188	83	6	f5102e8d95506c25c675094b86162a6a50087b64
ToppCell	NS-critical-d_0-4-Lymphoid-NKT-proliferating\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ESCO2 ZWILCH DTL MCM10 PRC1 MELK	1.46e-06	189	83	6	d6bd46abb072b13a6b72f1ca25d19f218cceb1ff
ToppCell	normal-na-Lymphocytic\|normal / PBMC cell types (v2) per disease, treatment status, and sex	ESCO2 DTL MCM10 PRC1 RRM1 MELK	1.46e-06	189	83	6	1d382f8eb998c6a30e09fddc9a427afc8f5f7323
ToppCell	normal-na-Lymphocytic-lymphocyte\|normal / PBMC cell types (v2) per disease, treatment status, and sex	ESCO2 DTL MCM10 PRC1 RRM1 MELK	1.46e-06	189	83	6	b83fd81ecc5ef363be7435ee12cb7079e2434af7
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ESCO2 DTL MCM10 PRC1 RRM1 MELK	1.46e-06	189	83	6	fd8834d1feb7f63911c5fa51efb1f679a8baddeb
ToppCell	normal-na-Lymphocytic-lymphocyte-female\|normal / PBMC cell types (v2) per disease, treatment status, and sex	ESCO2 DTL MCM10 PRC1 RRM1 MELK	1.46e-06	189	83	6	3db4177d68cab4cd16842d2ebcaca28f69300e44
ToppCell	normal_Pleural_Fluid-T/NK_cells-Undetermined\|normal_Pleural_Fluid / Location, Cell class and cell subclass	ESCO2 DTL MCM10 PRC1 RRM1 MELK	1.51e-06	190	83	6	165c61443ff0c8efbdad3b052bb00f46d81c5203
ToppCell	droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ESCO2 DTL MCM10 PRC1 RRM1 MELK	1.56e-06	191	83	6	15dbc5a03bfab8931c0fd385b0f25874736ae874
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ESCO2 DTL MCM10 PRC1 RRM1 MELK	1.56e-06	191	83	6	d6e158f16a183c9203c057192342e9b83e79bc89
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ESCO2 DTL MCM10 PRC1 RRM1 MELK	1.56e-06	191	83	6	7cb5c6f2cf27f3503d1b313e402a7410dfe6473e
ToppCell	3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T\|bone_marrow / Manually curated celltypes from each tissue	ESCO2 DTL MCM10 PRC1 RRM1 MELK	1.56e-06	191	83	6	210a0f1a71df2508cbfc73d6868a2122338b9a1c
ToppCell	droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ESCO2 DTL MCM10 PRC1 RRM1 MELK	1.56e-06	191	83	6	45c15f5ce4a207ac944bed65d45f06c1657d1a6d
ToppCell	P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ESCO2 ZWILCH MCM10 PRC1 RRM1 MELK	1.56e-06	191	83	6	b978afe76754cc56e1672abca27be289bb56375b
ToppCell	Proliferating\|World / shred by cell class for mouse tongue	ESCO2 ZWILCH MCM10 PRC1 RRM1 MELK	1.60e-06	192	83	6	f081f3f957cc782294e118fcc1055f6a4264ee98
ToppCell	NS-moderate-d_0-4-Lymphoid\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ESCO2 AOAH DTL MCM10 PRC1 MELK	1.60e-06	192	83	6	905217dcfc843d3469e9e71bd33707863b14cc82
ToppCell	RV-10._Endothelium_II\|RV / Chamber and Cluster_Paper	DOCK4 ANO2 AKT3 DOCK9 NRG3 IL6ST	1.65e-06	193	83	6	01c2df9206f1527c578e808978e58196c35e72f5
ToppCell	Severe_COVID-19-Myeloid-proliferating_Myeloid_cells\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	ESCO2 DST DTL MCM10 PRC1 RRM1	1.65e-06	193	83	6	0d85025690c9cd545cba30abc38acbdd6a39b153
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK4 TGFBR2 FAT4 AKT3 NRG3 IL6ST	1.65e-06	193	83	6	456aa8a8f1f9cbba0bd618a5f623909079c0f56b
ToppCell	RV-10._Endothelium_II\|World / Chamber and Cluster_Paper	DOCK4 ANO2 AKT3 DOCK9 NRG3 IL6ST	1.65e-06	193	83	6	2531266bc57339d4e2b22a88817008e32b8c1598
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ESCO2 DTL MCM10 PRC1 RRM1 MELK	1.65e-06	193	83	6	e45ce9cf8421512b57f157c24b64793b47b4ba4b
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ESCO2 DTL MCM10 PRC1 RRM1 MELK	1.70e-06	194	83	6	f39a471293ecc5c5967b00e772b8f48ebc9affbe
ToppCell	BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ESCO2 DST DTL MCM10 PRC1 RRM1	1.70e-06	194	83	6	cb39850e9577015b6b9834e98c36b412bae7d462
ToppCell	3'_v3-Lung-Myeloid_Mac-Cycling_Myeloid-Mac\|Lung / Manually curated celltypes from each tissue	ESCO2 DTL MCM10 PRC1 RRM1 MELK	1.70e-06	194	83	6	a8ae49157ca3f9e8b3f1750a995aee012dc859b6
ToppCell	BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ESCO2 DST DTL MCM10 PRC1 RRM1	1.70e-06	194	83	6	408597c9aa302a44b112c1d612c21fbb0227a82a
ToppCell	BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ESCO2 DST DTL MCM10 PRC1 RRM1	1.70e-06	194	83	6	193cc20fefbd795a4ad59e401a95af47d30603e7
ToppCell	BAL-Severe-Myeloid-Myeloid\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ESCO2 DST DTL MCM10 PRC1 RRM1	1.70e-06	194	83	6	2360b5f995b360419de41612368cab9fb61781a1
ToppCell	wk_20-22-Hematologic_Lymphocytic-B-Pro-B\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	ESCO2 DTL MCM10 PRC1 RRM1 MELK	1.70e-06	194	83	6	3590ff471f74a361ee5bf02a58e3104cd3bf7d00
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ESCO2 DTL MCM10 PRC1 RRM1 MELK	1.70e-06	194	83	6	f9070035553bc68106a9e0bdf4b507715a138aba
ToppCell	BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	ESCO2 DST DTL MCM10 PRC1 RRM1	1.70e-06	194	83	6	903ae11708b0cb24538c6982abd57fe6fa95b8d3
ToppCell	Control-Lymphoid_T/NK-T/NK_proliferative\|Control / Disease group, lineage and cell class	ESCO2 DTL MCM10 PRC1 RRM1 MELK	1.70e-06	194	83	6	9bbb124001fba7450f4639f47f9b720a483e7242
ToppCell	LPS-IL1RA-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 AKT3 DST MCTP1 DOCK9 DTL	1.70e-06	194	83	6	43f92b0533e26633dc94cce554045d641ef8fd76
ToppCell	Control-Lymphocyte-T_NK-T_NK_proliferative\|Control / Disease, Lineage and Cell Type	ESCO2 DTL MCM10 PRC1 RRM1 MELK	1.70e-06	194	83	6	844731b7943d1cfca819b7b89e4e62067bfa0230
ToppCell	BAL-Severe-Myeloid-Myeloid\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	ESCO2 DST DTL MCM10 PRC1 RRM1	1.70e-06	194	83	6	58406502a8cbcc3037f79a1b6a683df408297ae5
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ESCO2 DTL MCM10 PRC1 RRM1 MELK	1.70e-06	194	83	6	a75ecd0b0a928d4646602f7d16a645f6b3df3af5
ToppCell	LPS-IL1RA-Endothelial-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 AKT3 DST MCTP1 DOCK9 DTL	1.70e-06	194	83	6	1d39d968730a7e85b6161c1c8a6bd38afe9bcad7
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ESCO2 DTL MCM10 PRC1 RRM1 MELK	1.70e-06	194	83	6	4c1d13d8cb6fb424655c67755ee6dbaf59d6b418
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ESCO2 DTL MCM10 PRC1 RRM1 MELK	1.70e-06	194	83	6	17744fd6645cf5a447a01a83f07e8d305c2bcd9c
ToppCell	(7)_Epithelial_cells-(7)_Epithelial-J_(AT1-AT2_progenitors)\|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)	ESCO2 ZWILCH MCM10 PRC1 RRM1 MELK	1.70e-06	194	83	6	4d6ae2b25db11a4ae6dadee83be5c8c05b1225c3
ToppCell	367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating\|367C / Donor, Lineage, Cell class and subclass (all cells)	ESCO2 ZWILCH DTL MCM10 PRC1 MELK	1.70e-06	194	83	6	a12b64945e10f00aa983678a02586c59badc1570
ToppCell	control-Lymphocytic-Prol._cells\|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	ESCO2 ZWILCH DTL MCM10 RRM1 MELK	1.70e-06	194	83	6	4c76508de3291c952386caffda2d559629ba5998
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	ESCO2 DTL MCM10 PRC1 RRM1 MELK	1.70e-06	194	83	6	e14f66f7584909621b776292fbd52808273fd2ee
ToppCell	(7)_Epithelial-J_(AT1-AT2_progenitors)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	ESCO2 ZWILCH MCM10 PRC1 RRM1 MELK	1.76e-06	195	83	6	70e6b58c502a2abeb4e36bed179020c675468bd4
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ESCO2 ZWILCH DTL MCM10 RRM1 MELK	1.76e-06	195	83	6	cec7df321f372d05c94f97d6bb18891a5cc3dec3
Drug	benzoyl-S-CoA	ESCO2 DBT ESCO1 ARAF ACOT12	2.24e-06	58	83	5	CID000122174
Drug	Guanabenz acetate [23256-50-0]; Up 200; 13.8uM; PC3; HT_HG-U133A	AKT3 GGA2 CLCN5 DBT ANAPC5 ITPR1 ZNF3	7.03e-06	194	83	7	4642_UP
Drug	Fluoxetine hydrochloride [59333-67-4]; Down 200; 11.6uM; PC3; HT_HG-U133A	USP8 AKT3 GGA2 DBT PLEKHO1 SBNO2 ITPR1	7.52e-06	196	83	7	6757_DN
Drug	C04424	ESCO2 DBT ESCO1	7.55e-06	11	83	3	CID011953835
Drug	Naringin hydrate [11032-30-7]; Down 200; 6.6uM; HL60; HT_HG-U133A	GGA2 MACF1 C5 SNX16 DBT RRM1 TTF1	8.03e-06	198	83	7	2425_DN
Drug	C05118	ESCO2 DBT ESCO1	1.00e-05	12	83	3	CID000440565
Drug	C05119	ESCO2 DBT ESCO1	1.00e-05	12	83	3	CID000440566
Drug	AC1L9EUB	ESCO2 DBT ESCO1	1.30e-05	13	83	3	CID000443527
Drug	AC1LCVO5	ESCO2 DBT ESCO1	1.65e-05	14	83	3	CID000656890
Drug	AC1L9EU8	ESCO2 DBT ESCO1	1.65e-05	14	83	3	CID000443526
Drug	IC261	LMLN DNAH17 DNAH9 BDKRB2 DNAH11	2.69e-05	96	83	5	CID000003674
Drug	AC1L9ASI	ESCO2 DBT ESCO1	3.06e-05	17	83	3	CID000441230
Drug	2,4,4'-trichlorobiphenyl	ESCO2 SPTLC3 ZWILCH AKT3 TRANK1 MCTP1 MYO1B MCM10 MLXIP NRG3 PRC1 RRM1 MELK ESCO1 MPTX1 ITPR1	4.33e-05	1411	83	16	ctd:C081766
Drug	2,4,5,2',5'-pentachlorobiphenyl	ESCO2 SPTLC3 ZWILCH AKT3 TRANK1 MCTP1 MYO1B MCM10 MLXIP NRG3 PRC1 RRM1 MELK ESCO1 MPTX1 ITPR1	5.57e-05	1441	83	16	ctd:C009828
Drug	Homatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; PC3; HT_HG-U133A	TGFBR2 GGA2 UGT8 SNX16 DBT ANAPC5	7.32e-05	192	83	6	5058_DN
Drug	2-propylpentanoic acid; Down 200; 50uM; MCF7; HT_HG-U133A	GGA2 PIK3CA MYO1B C5 RRM1 ANAPC5	7.32e-05	192	83	6	1647_DN
Drug	STOCK1N-35215; Up 200; 10uM; MCF7; HT_HG-U133A	PHEX SPTLC3 AKT3 DNAH17 SCNN1B ZNF3	7.54e-05	193	83	6	6422_UP
Drug	Prochlorperazine dimaleate [84-02-6]; Up 200; 6.6uM; MCF7; HT_HG-U133A	KLHL29 FAT4 DOCK9 DBT IL6ST SBNO2	8.44e-05	197	83	6	2641_UP
Drug	Thiorphan [76721-89-6]; Up 200; 15.8uM; MCF7; HT_HG-U133A	DOCK4 DRD2 DBT DNAH9 IL6ST ITPR1	8.44e-05	197	83	6	2752_UP
Drug	Fluorocurarine chloride [22273-09-2]; Up 200; 11.6uM; MCF7; HT_HG-U133A	ANO2 DRD2 SCNN1B LRP2 NIPAL3 ITPR1	8.44e-05	197	83	6	6083_UP
Drug	Debrisoquin sulfate [581-88-4]; Up 200; 9uM; PC3; HT_HG-U133A	PHEX AKT3 DRD2 DOCK9 MYO1B MLXIP	8.44e-05	197	83	6	6688_UP
Drug	Clindamycin hydrochloride [21462-39-5]; Up 200; 8.6uM; PC3; HT_HG-U133A	KLHL29 DRD2 GGA2 DOCK9 DBT IL6ST	8.68e-05	198	83	6	2057_UP
Drug	5140203; Up 200; 15uM; MCF7; HT_HG-U133A_EA	SPTLC3 CLCN5 MYO1B C5 ANAPC5 BDKRB2	8.68e-05	198	83	6	908_UP
Drug	Ethotoin [86-35-1]; Up 200; 19.6uM; MCF7; HT_HG-U133A	KLHL29 ANO2 DOCK9 DNAH17 MUC2 ITPR1	8.68e-05	198	83	6	3892_UP
Drug	Nifedipine [21829-25-4]; Down 200; 11.6uM; PC3; HT_HG-U133A	TGFBR2 GGA2 MCTP1 XPA C5 DBT	8.68e-05	198	83	6	7303_DN
Disease	Vitamin D-Resistant Rickets, X-Linked	PHEX CLCN5	7.44e-06	2	81	2	C3536984
Disease	Hypophosphatemic Rickets, X-Linked Dominant	PHEX CLCN5	7.44e-06	2	81	2	C0733682
Disease	Rickets, X-Linked Hypophosphatemic	PHEX CLCN5	7.44e-06	2	81	2	C3540852
Disease	Hypophosphatemic Rickets, X-Linked Recessive	PHEX CLCN5	7.44e-06	2	81	2	C1845168
Disease	Weight Gain	ZWILCH DRD2 PIK3CA MYO1B DNAH11	9.30e-06	102	81	5	C0043094
Disease	hair morphology measurement	MCTP1 AOAH MLXIP NRG3	1.50e-05	54	81	4	EFO_0007821
Disease	amino acid measurement	KLHL29 ANO2 FAT4 NPSR1 SCNN1B LRP2 C5 MLXIP NRG3 MUC2	1.66e-05	678	81	10	EFO_0005134
Disease	Familial Hypophosphatemic Rickets	PHEX CLCN5	2.23e-05	3	81	2	C3536983
Disease	morphine dependence (biomarker_via_orthology)	DRD2 NPSR1	2.23e-05	3	81	2	DOID:2560 (biomarker_via_orthology)
Disease	Megalanecephaly Polymicrogyria-Polydactyly Hydrocephalus Syndrome	AKT3 PIK3CA	4.45e-05	4	81	2	C1863924
Disease	Roberts syndrome (implicated_via_orthology)	ESCO2 ESCO1	4.45e-05	4	81	2	DOID:5325 (implicated_via_orthology)
Disease	Cleft palate	PHEX POMGNT2 SCNN1B NIPAL3	4.45e-05	71	81	4	HP_0000175
Disease	Hypophosphatemic rickets	PHEX CLCN5	7.40e-05	5	81	2	cv:C1704375
Disease	Hereditary hypophosphatemic rickets	PHEX CLCN5	7.40e-05	5	81	2	cv:CN296404
Disease	Rickets	PHEX CLCN5	7.40e-05	5	81	2	cv:C0035579
Disease	Hemimegalencephaly	AKT3 PIK3CA	1.11e-04	6	81	2	C0431391
Disease	asthma (implicated_via_orthology)	C5 BDKRB2 ITPR1	1.22e-04	35	81	3	DOID:2841 (implicated_via_orthology)
Disease	primary immunodeficiency disease (is_implicated_in)	MCM10 IL6ST POLR3F	2.12e-04	42	81	3	DOID:612 (is_implicated_in)
Disease	Bipolar Disorder	DRD2 TRANK1 DOCK9 NRG3 PLEKHO1 BDKRB2 ITPR1	3.43e-04	477	81	7	C0005586
Disease	C-reactive protein measurement	DOCK4 AKT3 RBM25 TRANK1 DNAH17 MACF1 ANAPC5 MPTX1 ITPR1 DNAH11 ZNF3	4.48e-04	1206	81	11	EFO_0004458
Disease	Intestinal Neoplasms	XPA MUC2	4.83e-04	12	81	2	C0021841
Disease	Intestinal Cancer	XPA MUC2	4.83e-04	12	81	2	C0346627
Disease	melanoma	FAT4 AKT3 PIK3CA MYO1B XPA	6.14e-04	248	81	5	C0025202
Disease	Malformations of Cortical Development	AKT3 PIK3CA	6.63e-04	14	81	2	C1955869
Disease	Cortical Dysplasia	AKT3 PIK3CA	6.63e-04	14	81	2	C0431380
Disease	cancer (implicated_via_orthology)	AKT3 DST MACF1 NOP2 ARAF	8.69e-04	268	81	5	DOID:162 (implicated_via_orthology)
Disease	asthma (is_implicated_in)	NPSR1 C5 MUC2 BDKRB2	9.34e-04	157	81	4	DOID:2841 (is_implicated_in)
Disease	adenosine monophosphate measurement	MYO1B RRM1	1.11e-03	18	81	2	EFO_0010454
Disease	sensorineural hearing loss (implicated_via_orthology)	DNAH17 DNAH9	1.23e-03	19	81	2	DOID:10003 (implicated_via_orthology)
Disease	Corneal astigmatism	DOCK9 AOAH BDKRB2	1.26e-03	77	81	3	EFO_1002040
Disease	Bronchiectasis	SCNN1B DNAH11	1.66e-03	22	81	2	C0006267
Disease	visual epilepsy (biomarker_via_orthology)	RTN4 RRM1 IL6ST	1.97e-03	90	81	3	DOID:11832 (biomarker_via_orthology)
Disease	gout	DST LRP2 MLXIP BDKRB2	2.11e-03	196	81	4	EFO_0004274
Disease	Hereditary non-polyposis colorectal cancer syndrome	TGFBR2 PIK3CA	2.50e-03	27	81	2	C1112155
Disease	Adenocarcinoma of lung (disorder)	PIK3CA RRM1 TTF1 ARAF	2.52e-03	206	81	4	C0152013
Disease	Pigmented Basal Cell Carcinoma	PIK3CA XPA	2.69e-03	28	81	2	C1368275
Disease	Liver carcinoma	PIK3CA DTL MCM10 PRC1 RRM1 MELK	2.73e-03	507	81	6	C2239176

Protein segments in the cluster

Peptide	Gene	Start	Entry
IVREKLYKGISWVEV	TTF1	711	Q15361
GVIEDWKRITKLDIY	ACSM6	351	Q6P461
VYVIVGKRFRKKSWE	BDKRB2	331	P30411
VIDYIDTIWKILKPG	CARNMT1	321	Q8N4J0
WRVKGKTIKEVAEAY	ALDH1L2	81	Q3SY69
KIQKYVVWIEARDGG	FAT4	2631	Q6V0I7
LKGLWDVIIYVRRSI	DNAH11	1326	Q96DT5
RGWEVTSTVEKIKIY	ACOT12	366	Q8WYK0
VDGIIKVWDLRKNYT	DTL	236	Q9NZJ0
LDEIYGAVAKWLTKI	ANO2	596	Q9NQ90
IVKEGWVQKRGEYIK	AKT3	6	Q9Y243
IRPWINKKIIEYIGE	RBM25	771	P49756
LKGDAWVYKRLVEDI	MELK	631	Q14680
IKDWVTPYKIAVLVL	ANAPC5	26	Q9UJX4
TVGIKEKSIYLRLWK	AOAH	311	P28039
LKWIVVGSVKEYVPT	NRG3	86	P56975
IREVTVKEWYVKEGD	DBT	76	P11182
KVYRALWRGEEVAVK	MAP3K10	111	Q02779
IASAIIGIIFIKEKW	NIPAL3	111	Q6P499
LRYIVLVWGINKFTK	MCTP1	936	Q6DN14
GIVIRTIWIKSKTYE	NPSR1	231	Q6W5P4
QLRSIVEKSELWVYK	ITPR1	1131	Q14643
IKRLYKLLEIWIEFG	DST	331	Q03001
TYEIIFKIVGTKWLA	DOP1B	86	Q9Y3R5
LGLYQWSDKVVRKVE	LMLN	311	Q96KR4
YIISEELISEGKWVK	NUDT5	16	Q9UKK9
IIVIWDKRTTVFIKL	MUC2	966	Q02817
TGVEYIVTVKIGWTK	CSTL1	76	Q9H114
VNIAVIKYWGKRDEE	MVD	16	P53602
IKYWGKRDEELVLPI	MVD	21	P53602
DSKSVKEIYIRGWKV	LRRC71	136	Q8N4P6
KEIYIRGWKVEERIL	LRRC71	141	Q8N4P6
KVKGRVIEILFSWTV	GGA2	126	Q9UJY4
IEVAKLDGRYRKWLI	LRP2	4166	P98164
EIDWVTFGVILKKVT	MCM10	291	Q7L590
KVREVKYEVWLQEQG	POMGNT2	516	Q8NAT1
SDLVEIYLWKLVKGI	CHRDL2	361	Q6WN34
IYNKLDKGQIIVVIW	PIK3CA	181	P42336
KGRIEELYKLLEVWI	MACF1	371	Q9UPN3
ELYKLLEVWIEFGRI	MACF1	376	Q9UPN3
KVTQEVIDYRRWIKE	TENT4A	516	Q5XG87
TEGKYWKSRIEIVIR	MLXIP	206	Q9HAP2
VYRLIKGRKTVTAWD	ARAF	61	P10398
VEWTTPRESVKKYIL	IL6ST	441	P40189
RDLIKVLKWYVDRIT	DOCK4	676	Q8N1I0
KKRDVVETQVGYSWL	DOCK9	746	Q9BZ29
VGWYNEIKTIVKAVE	DNAH17	721	Q9UFH2
TKGRVKLVIFVIWAV	GHSR	156	Q92847
EIKKVWYGRTIIRSA	DIS3L	571	Q8TF46
TWFGKEILVKTLRVV	C5	916	P01031
GILLEWKTVTEKELY	UGT8	396	Q16880
IIRGYLGKWTLVIKT	CLCN5	251	P51795
EGIKYVGWKKERVVA	ESCO2	416	Q56NI9
SAVKYVGWKKERILA	ESCO1	646	Q5FWF5
VIKWSYQVQVVLKRE	DNAH9	221	Q9NYC9
VVYLEVVGEWKFSRI	DRD2	91	P14416
ADKYEIKIWPIGREI	FBXW2	296	Q9UKT8
QRWLKVRDLTKGVTY	SDK1	1861	Q7Z5N4
GEIIIDFVWITIIKL	SCNN1B	541	P51168
WVIDKYGKNEVLRFT	RTN4IP1	46	Q8WWV3
VDLLYWRDIKKTGVV	RTN4	1006	Q9NQC3
EIVRTKEYEGNLTWK	TAS2R31	151	P59538
LSVLRQVRYWVKGEK	TAS2R31	291	P59538
KKVIEAIRVELVQYW	PRC1	291	O43663
EERKTELGKQYWLIT	TGFBR2	311	P37173
QVVFYKISVDRGLKW	SBNO2	1036	Q9Y2G9
VWKGYSVGEEAKIIL	MPTX1	56	A8MV57
VWKYICELGISKVEL	POLR3F	216	Q9H1D9
RRAWKKILILVEGVY	SPTLC3	296	Q9NUV7
WVVDYALKKRNVRLV	NOP2	526	P46087
IFREIWKNRYVVLKG	PLEKHO1	36	Q53GL0
TYVKEIEVWRRLVEI	RNF213	931	Q63HN8
WRVEIYSGQKKIKTV	ZWILCH	531	Q9H900
VAVYFIRKEWKRLEP	ZNF3	56	P17036
TGKLLWKVRYDTFIV	WDR88	176	Q6ZMY6
RKVVKAQQLWYAIIE	RRM1	381	P23921
TIKLWDYIDGILIKT	WDR75	81	Q8IWA0
QFDWLGYIKKVIDTR	PHEX	311	P78562
YLKLQIVKRSLEVWG	XPA	181	P23025
KLVALYTVWVALKEV	PIEZO1	816	Q92508
KSGRIYTEIIRIWDI	TRANK1	886	O15050
VYKILVKKTPEESWV	SNX16	126	P57768
TWKKRGNVEYVVLLD	USP8	246	P40818
RIVVLGIWDYIENKI	TMEM266	156	Q2M3C6
KQRIIWGYKILFLDV	UGGT1	1331	Q9NYU2
TKAEELVYETVIKWI	KLHL29	491	Q96CT2
VIQSYIRGWKARKIL	MYO1B	756	O43795